49 125

Cited 0 times in

Respiratory syncytial virus prevention in children with congenital heart disease: who and how?

Authors
 Nam Kyun Kim  ;  Jae Young Choi 
Citation
 Korean Journal of Pediatrics, Vol.54(5) : 197-200, 2011 
Journal Title
 Korean Journal of Pediatrics 
ISSN
 1738-1061 
Issue Date
2011
Abstract
Respiratory syncytial virus (RSV) is a major cause of respiratory infection in children. Most of the pediatric population have RSV infection before the age of 2, and recurrent infections are common even within one season. Chronic lung disease, prematurity, along with congenital heart disease (CHD) are major risk factors in severe lower respiratory infection. In hemo-dynamically significant CHD patients with RSV infection, hospitalization is usually needed and the possibility of treatment in intensive care unit and the use of mechanical ventilator support are known to increase. Therefore the prevention of RSV infection in CHD patients is mandatory. The current standard for RSV prevention is immunoprophylaxis by palivizumab. Immunoprophylaxis is recommended monthly in hemodynamically significant CHD patients, up to 5 months. Motabizumab, a second generation drug and newly developing RSV vaccines are also expected to play a key role in RSV prevention in the future. The prophylaxis of RSV infection in CHD patients is cost-effective in both the medical aspect of the patients as well as the socio-economic aspect. Therefore an effort to promote prevention should be made by not only the family of the patients but also by the government
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/94071
DOI
10.3345/kjp.2011.54.5.197
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Pediatrics (소아청소년과학교실)
Yonsei Authors
김남균(Kim, Nam Kyun) ; 최재영(Choi, Jae Young)
사서에게 알리기
  feedback
Files in This Item:
T201103228.pdf Download
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse